Latest Breaking News On - Director bakker juliet tammenoms - Page 1 : comparemela.com

RxSight (NASDAQ:RXST) Posts Quarterly Earnings Results, Misses Expectations By $0 08 EPS

RxSight (NASDAQ:RXST) Posts Quarterly Earnings Results, Misses Expectations By $0 08 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBakker juliet tammenomsStifel nicolausShelleyb thunenNeedham companyWells fargo companyRxsight incSecurities exchange commissionJpmorgan chase coGet free reportSight stock downExchange commissionDirector bakker juliet tammenomsWells fargoRxsight daily

Needham & Company LLC Increases RxSight (NASDAQ:RXST) Price Target to $75 00

Needham & Company LLC Increases RxSight (NASDAQ:RXST) Price Target to $75 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesBakker juliet tammenomsStifel nicolausShelleyb thunenHightower advisorsLarson financial groupNeedham companyRxsight incRxsight company profileRiverpark advisorsJpmorgan chase coSecurities exchange commissionGet free reportDirector bakker juliet tammenomsExchange commissionPark advisors

RxSight (NASDAQ:RXST) Price Target Raised to $68 00 at Wells Fargo & Company

RxSight (NASDAQ:RXST) Price Target Raised to $68 00 at Wells Fargo & Company
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesShelleyb thunenBakker juliet tammenomsStifel nicolausSecurities exchange commissionRiverpark advisorsClarus group incJpmorgan chase coWells fargo companyLarson financial groupRxsight company profileClear rock advisorsRxsight incNeedham companyGet free reportWells fargo

RxSight (NASDAQ:RXST) Given New $61 00 Price Target at Oppenheimer

RxSight (NASDAQ:RXST – Get Free Report) had its price objective increased by analysts at Oppenheimer from $54.00 to $61.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price target points to a potential upside of 8.73% from the stock’s […]

United statesNew yorkStifel nicolausBakker juliet tammenomsAllspring global investments holdingsMorgan stanleyRxsight incWells fargo companyNeedham companyYork state common retirement fundArtisan partners limited partnershipVictory capital management incLisanti capital growthGet free reportDirector bakker juliet tammenomsCapital growth

RxSight (RXST) to Release Quarterly Earnings on Wednesday

RxSight (NASDAQ:RXST – Get Free Report) is set to release its earnings data after the market closes on Wednesday, February 28th. Analysts expect RxSight to post earnings of ($0.36) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. RxSight Price Performance Shares of […]

United statesStifel nicolausBakker juliet tammenomsEric weinbergRxsight incRxsight company profileSteward partners investment advisoryMorgan stanleySecurities exchange commissionLazard asset managementBarclays plcCubist systematic strategiesNeedham companyWells fargo companyGet free reportDirector bakker juliet tammenoms